Cancer Epidemiology
Volume 34, Issue 2 , Pages 162-167 , April 2010

Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, Central Italy

,Accepted 9 December 2009.

References 

  1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265
  2. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907
  3. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24(Suppl. 1):S1–15
  4. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–459
  5. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(Suppl. 10):K1–16
  6. Munoz N, Bosch FX, de SS, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527
  7. Wheeler CM. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol. 2007;4(April):224–235
  8. World Health Organization (WHO). International Agency for Research on Cancer (IARC). Human papillomavirus. IARC monographs on the evaluation of carcinogenic risk to humans, vol. 90. International Agency for Research on Cancer; 2007.
  9. Chan PK, Luk AC, Luk TN, Lee KF, Cheung JL, Ho KM, et al. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol. 2009;44:111–114
  10. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 2008;68:8813–8824
  11. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol. 2009;81:529–535
  12. Carozzi F, Bisanzi S, Sani C, Zappa M, Cecchini S, Ciatto S, et al. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease. J Clin Microbiol. 2007;45:364–369
  13. Martinelli D, Chironna M, Tafuri S, Neve A, Caputi G, Prato Ret al. Epidemiologia delle infezioni da HPV e del cervicocarcinoma in Puglia: studi ad hoc e analisi dei dati correnti (Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis), Ann Ig. 2007;19:499–508
  14. Menzo S, Ciavattini A, Bagnarelli P, Marinelli K, Sisti S, Clementi M. Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types. BMC Microbiol. 2008;8:112
  15. Broccolo F, Chiari S, Piana A, Castiglia P, Dell’Anna T, Garcia-Parra R, et al. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy. J Med Virol. 2009;81:278–287
  16. Centurioni MG, Puppo A, Merlo DF, Pasciucco G, Cusimano ER, Sirito R, et al. Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis. 2005;5:77
  17. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol. 2005;75:588–592
  18. Verteramo R, Pierangeli A, Calzolari E, Patella A, Recine N, Mancini E, et al. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect. 2006;8:2517–2521
  19. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev. 2008;17:2002–2006
  20. Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R, Miragliotta G. Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol. 2008;42:211–214
  21. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV vaccination program in Denmark. Int J Cancer. 2008;123:1864–1870
  22. Pannier-Stockman C, Segard C, Bennamar S, Gondry J, Boulanger JC, Sevestre H, et al. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol. 2008;42:353–360
  23. Hibbitts S, Jones J, Powell N, Dallimore N, McRea J, Beer H, et al. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer. 2008;99:1929–1933
  24. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer. 2008;44:557–564
  25. Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201(1):1–6
  26. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006;24(Suppl. 3):S3/52–S/10
  27. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 Suppl.):S5-25, S25.e1-41
  28. Kovács K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, et al. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J Med Virol. 2008;80:1814–1823
  29. Dal Bello BD, Spinillo A, Alberizzi P, Cesari S, Gardella B, D’Ambrosio G, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol. 2009;81:703–712
  30. Hamlin-Douglas LK, Coutlée F, Roger M, Franco EL, Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev. 2008;17:3141–3149
  31. Mejlhede N, Bonde J, Fomsgaard A. High frequency of multiple HPV types in cervical specimens from Danish women. APMIS. 2009;117:108–114
  32. Ragin CC, Watt A, Markovic N, Bunker CH, Edwards RP, Eckstein S, et al. Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer. 2009;4(Suppl. 1):S9
  33. Simen-Kapeu A, La Ruche G, Kataja V, et al. Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d’Ivoire and Finland) with different tobacco exposure. Cancer Causes Control. 2009;20:163–170
  34. Watt A, Garwood D, Jackson MN, Ragin C, Smikle M, et al. High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women. Infect Agent Cancer. 2009;4(Suppl. 1):S11
  35. Werden J, Schnatz PF, Mandavilli S, Allen G, Murphy JL, Greene JF, et al. Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests. J Low Genit Tract Dis. 2008;12:287–292
  36. Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank ME, et al. Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer. 2007;97:133–139
  37. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev. 2006;15:2148–2153
  38. Green J, Berrington de Gonzalez A, Smith JS, Franceschi S, Appleby P, Plummer M, et al. Human papillomavirus infection and use of oral contraceptives. Br J Cancer. 2003;88:1713–1720
  39. Beby-Defaux A, Bourgoin A, Ragot S, Battandier D, Lemasson JM, Renaud O, et al. Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security. J Med Virol. 2004;73:262–268
  40. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev. 2003;12:1029–1037
  41. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24(Suppl. 3):S3/1–S/10
  42. Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24(Suppl. 3):S3/26–S/10

PII: S1877-7821(09)00189-1

doi: 10.1016/j.canep.2009.12.010

Cancer Epidemiology
Volume 34, Issue 2 , Pages 162-167 , April 2010

Article Tools

* Image Usage & Resolution